Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.20826 | 8 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.18306 | 8 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.18535 | 8 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.13232 | 8 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.1282 | 7 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.30688 | 10 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.18523 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.16212 | 8 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.15036 | 8 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.17063 | 8 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.16641 | 8 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.15542 | 8 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.18154 | 8 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.17352 | 8 |